Novel Pharmacological and Nanotechnology-Based Therapeutic Strategies for MASLD
Elda Cristina Villaseñor-Tapia, Adriana Franco-Acevedo, Rebeca Rosas-Campos, Juan Armendariz-Borunda · 2026
Read Novel Pharmacological and Nanotechnology-Based Therapeutic Strategies for MASLD by Elda Cristina Villaseñor-Tapia, Adriana Franco-Acevedo, Rebeca Rosas-Campos, Juan Armendariz-Borunda (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13210413.txt.
Description
Elda Villasenor-Tapia and three co-authors review new treatments in 2026 for a common liver disease tied to excess fat and metabolic problems. The disease can progress from fat buildup to inflammation, scarring, and in some cases liver cancer. Current care rests mostly on lifestyle change, with limited long term success.
The review covers several drug classes that improve metabolic measures and reduce liver fat, though their effect on scarring is still unclear. It also covers gene based therapies and tiny particle delivery systems that may target drugs more precisely. Most of these newer options are still in early testing. The authors call for stronger trials and shared standards before wide use.
Catalog record
| CREATOR | Elda Cristina Villaseñor-Tapia, Adriana Franco-Acevedo, Rebeca Rosas-Campos, Juan Armendariz-Borunda |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |